Pharmafile Logo
Pharmafocus logo
Advanced Search

Lessons from the world of iPad detailing

October 27, 2011
Medical Communications

This is an article for those who have chosen the iPad as an e-detailing tool. It’s not an argument on …

Feature
Thought Leadership
Social moon image

Alex Butler leaves Janssen to set up Social Moon pharma network

October 27, 2011
Medical Communications Alex Bytler, Jansse, Janssen, comms

Social media guru Alex Butler has left Janssen to establish Social Moon, a digital-only marketing and comms agency for the …

News
Lansley speach

Lansley talks tough on failing hospitals

October 27, 2011
Medical Communications Andrew Lansley, NHS reforms

The health secretary Andrew Lansley says he will intervene to remove management boards of hospitals which can’t clear debts or …

News

Biogen’s MS drug hits phase III targets

October 27, 2011
Sales and Marketing BG-12, Biogen, MS

Biogen’s potential blockbuster MS drug BG-12 has met its primary endpoint in a late-stage trial.   BG-12 (dimethyl fumarate) tablets …

News
GSK logo

GSK sees strong Q3 after battling headwinds

October 27, 2011
Business Services, Sales and Marketing GSK, GSK. Q3, Q3

GlaxoSmithKline has posted a set of healthy figures for the third quarter, underlying its return to growth after a tough …

News
NICE building

Mepact wins NICE backing

October 26, 2011
Research and Development, Sales and Marketing Mepact, NICE

NICE has recommended Takeda’s bone cancer drug Mepact after the firm offered a discount for the treatment. The watchdog’s final …

News

Reforms raise conflicts of interest, say GPs

October 25, 2011
Sales and Marketing BMA, NHS, NHS reforms

Two-thirds of doctors believe that the government’s health reforms will create conflicts of interests in their jobs and undermine their …

News
Novartis HQ

Novartis to cut 2,000 jobs

October 25, 2011
Manufacturing and Production, Research and Development

Novartis will cut around 2,000 jobs is the US and Switzerland as part of additional cost saving measures. The positions …

News

David Meeker appointed as chief executive of Genzyme

October 25, 2011
Research and Development, Sales and Marketing Genzyme, Sanofi

Sanofi has appointed David Meeker as chief executive of its new biotech acquisition Genzyme. He will report to Christopher Viehbacher, …

Appointment

Pharma manufacturing news in brief

October 25, 2011
Manufacturing and Production pharma manufacturing news

Patheon wins a new contract from Boehringer Ingelheim, Ferring buys a UK plant, plus updates from InvaGen, CrossJect and contract …

News

New venture a ‘game-changer’ for pharma

October 25, 2011
Research and Development Sir Christopher Evans, drug development

Sir Christopher Evans is looking to create a new venture that aims to improve on the drug development productivity of …

News
GSK HQ

GSK warned by FDA about Worthing plant

October 25, 2011
Manufacturing and Production

The US FDA has issued a warning letter to GlaxoSmithKline, noting that its manufacturing plant in Worthing, UK, failed to …

News
Sanofi HQ

Sanofi’s Lemtrada beats Rebif in MS study

October 25, 2011
Research and Development, Sales and Marketing Lemtrada, Sanofi

Sanofi’s investigational multiple sclerosis drug Lemtrada has beaten Rebif in a late-stage trial. The Phase III results show that 78% …

News

Flamel secures production contract for GSK heart failure drug

October 25, 2011
Manufacturing and Production Coreg CR, Flamel, GSK, manufacturing

France’s Flamel Technologies has won a long-term contract from GlaxoSmithKline focusing on the production of the drugmaker’s Coreg CR heart …

News

Risk Based Inspections for good pharmacovigilance practice

October 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recently in the UK there has been a move towards risk-based inspection programmes.  The scope, frequency and depth of MHRA …

News
Press release
Twitter feed

#fakedrugs: Scammers using Twitter to peddle fake medicines

October 24, 2011
Medical Communications Digital Pharma blog, Twitter

 Scammers are exploiting Twitter to entice people into buying fake medicines, according to a new report. The report, published by …

News
Lab image

Does drug development deliver on its promises?

October 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, R&D

I am always guided by the motto of the Royal Society, ‘Nullius in Verba’. This means, with typical Latin brevity: …

Feature

TranslateMedia listed in Deloitte UK Technology Fast 50 for 2011

October 24, 2011

The Deloitte UK Technology Fast 50 was founded in 1998, and remains one of Britain’s foremost technology programs. The program …

News
Press release
Merck image

Merck to invest $1billion in Singapore R&D and manufacturing

October 24, 2011
Manufacturing and Production, Research and Development

Singapore has reinforced its position as a major pharmaceutical hub for the Asia-Pacific region with the news that Merck is …

News

Bristol-Myers Squibb makes three senior management changes

October 24, 2011
Medical Communications, Research and Development, Sales and Marketing BMS

BMS has made three changes to its senior management with Giovanni Caforio promoted to president of US pharmaceuticals and Charles …

Appointment
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026